Jeffrey E. Jacob - Oct 4, 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4
Date filed
10/6/2022, 05:24 PM
Previous filing
Jun 27, 2022
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBLA Common Stock Purchase +33K +12.6% 295K Oct 4, 2022 Direct F1
holding PBLA Common Stock 17.8K Oct 4, 2022 Jointly with spouse
holding PBLA Common Stock 54.4K Oct 4, 2022 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Warrants (right to buy) Purchase $0 +49.5K $0.00 49.5K Oct 4, 2022 Common Stock 49.5K $0.30 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.